All In Biotech

Drug Trial Radar · NCT05641688

[18F]PI-2620 Phase 3 Histopathological Study

An Open-label, Non-randomized, Multi-center Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of PET Imaging With [18F]PI-2620 for the Detection of Tau Deposition When Compared to Post-mortem Histopathology (ADvance)

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Title says "pivotal". This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Dec 1, 2022

Primary completion

Mar 2028

Study completion Sep 2028

Sponsor

Lead sponsor
Lantheus Biosciences Ltd.Industry
Sponsor type
Industry
First posted
Dec 8, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after death and completion of brain autopsy.

Conditions

  • Alzheimer Disease

Interventions

  • [18F]PI-2620Drug

    The radioligand, \[18F\]PI-2620, will be injected intravenously at a dose of 185 MBq ± 20%

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diagnostic Efficacy of the visual assessment of [18F]PI-2620 PET imaging, in correctly differentiating tau neurofibrillary pathology associated with AD (NFT Score of B0 or B1 = negative)Time frame: At autopsy, until study completion with an average of 1 year

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Barrow Neurological Institute

    Phoenix, Arizona · Recruiting

  • Banner Sun Health Research Institute

    Sun City, Arizona · Recruiting

  • UC Los Angeles

    Los Angeles, California · Recruiting

  • Esperanza Clinical

    Murrieta, California · Recruiting

  • Sutter Health

    San Francisco, California · Recruiting

  • Galiz Research

    Hialeah, Florida · Recruiting

  • UF College of Medicine - Jacksonville

    Jacksonville, Florida · Withdrawn

  • K2 Medical Research

    Lady Lake, Florida · Recruiting

  • K2 Medical Research

    Maitland, Florida · Recruiting

  • ClinCloud Research

    Melbourne, Florida · Recruiting

  • Miami Jewish Health Systems

    Miami, Florida · Recruiting

  • The Roskamp Institute

    Sarasota, Florida · Terminated

  • Charter Research

    Winter Park, Florida · Recruiting

  • Alzheimer's Disease Center

    Braintree, Massachusetts · Recruiting

  • Headlands Research

    Plymouth, Massachusetts · Withdrawn

  • Be Well Clinical Studies

    Lincoln, Nebraska · Withdrawn

  • Darthmouth-Hitchcock Medical Center

    Lebanon, New Hampshire · Terminated

  • Velocity Clinical Research

    East Syracuse, New York · Terminated

  • Ichor Research

    Syracuse, New York · Recruiting

  • American Carolina Clinical Research LLC

    Charlotte, North Carolina · Terminated

  • Insight Clinical Trials LLC

    Beachwood, Ohio · Recruiting

  • Valley Medical Research

    Centerville, Ohio · Recruiting

  • Baylor Research Institute

    Dallas, Texas · Recruiting

  • Sante Clinical Research

    Kerrville, Texas · Recruiting

  • Be Well Clinical Studies

    Round Rock, Texas · Terminated

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.